This opportunity is no longer accepting applications.
grant RFA-HL-23-014

Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed)

This grant opportunity offers funding for early stage projects focused on developing and testing prototypes, creating diagnostic assays for disease targets, and developing research tools related to heart, lung, blood, and sleep (HLBS) diseases. The goal is to progress these projects to a stage where they can qualify for further development through the NHLBI Catalyze Preclinical program or secu…

This Funding Opportunity Announcement (FOA) will provide the early stage translational support needed for prototype testing/design modification, assay development for diagnostic disease targets, and development of research tools for use in the treatment of HLBS diseases and disorders. This FOA i…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Heart, Lung, and Blood Institute

Awards & funding

Award Ceiling: $250,000
Award Amount: $250,000

Dates

Opportunity Released: January 24, 2022
Open for Submission: January 24, 2022
Submission Deadline: December 20, 2024
Application Window Closes: December 20, 2024

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.